Ketoconazole Shortage Update: What Patients Need to Know in 2026

Patients and caregivers searching for ketoconazole often want to know: is there actually a shortage, or is my pharmacy just not stocking it? The answer in 2026 is nuanced — no FDA-declared national shortage exists for ketoconazole tablets or most topical forms, but there are real availability challenges patients need to understand.

Current Ketoconazole Availability Status (2026)

As of 2026, the FDA's drug shortage database does not list ketoconazole tablets or generic topical ketoconazole as being in national shortage. Generic ketoconazole 200 mg oral tablets and 2% topical cream are produced by multiple manufacturers and are generally available at most major retail pharmacies in the United States.

However, several formulations and brand-name products have had turbulent histories:

Extina foam (2% ketoconazole): This branded formulation has experienced periodic distribution gaps and may not be consistently stocked at all pharmacies.

Xolegel gel (2% ketoconazole): A specialty gel formulation for seborrheic dermatitis of the scalp. Less widely stocked than cream or shampoo and may need to be special-ordered.

Nizoral brand shampoo 2%: Brand-name prescription shampoo; generic versions are more broadly available.

Historical Context: Why Ketoconazole Has Had a Complicated Story

Understanding ketoconazole's availability challenges requires a bit of history. In 2013, the FDA issued a major safety warning for oral ketoconazole — citing cases of serious hepatotoxicity, including deaths and liver transplants. The agency downgraded oral ketoconazole from a broad-use antifungal to a last-resort option, recommending it only when other antifungals have failed.

That same year, the European Medicines Agency (EMA) recommended banning oral ketoconazole for systemic use entirely in EU countries, concluding that the liver damage risk outweighed the benefits. As a result, prescriptions for oral ketoconazole dropped substantially worldwide — which in turn reduced how much manufacturers produce and how widely pharmacies stock it.

The topical formulations were not part of the hepatotoxicity concerns (since systemic absorption from the skin is minimal) and remained fully approved. However, market forces led some topical ketoconazole brands to reduce production or exit the market, contributing to the variability patients see today.

What Patients Are Experiencing in 2026

While no active national shortage exists, patients across the country are reporting:

Smaller pharmacies and independents frequently having to order ketoconazole rather than keeping it on the shelf

Brand-name topical products (foam, gel) requiring advance ordering at most pharmacies

Occasional stock-outs at individual pharmacies due to distributor allocation issues

Price variation depending on formulation and whether a coupon is used

Which Patients Are Most Affected?

Patients most likely to face ketoconazole availability challenges include:

Those prescribed branded topical products (Extina, Xolegel) rather than generics

Patients in rural areas with fewer pharmacy options nearby

Patients who are prescribed oral ketoconazole as a last resort for endemic mycoses — since oral tablets are less commonly stocked than topical forms

Anyone using a small independent pharmacy that orders on-demand rather than stocking ketoconazole proactively

What Can Patients Do?

If you can't find ketoconazole at your pharmacy, here are immediate steps to take:

Use medfinder: medfinder.com calls pharmacies near you to find which ones have your medication ready to dispense today.

Ask for a generic: If you have a brand-name prescription, ask your prescriber if generic ketoconazole 2% cream is therapeutically equivalent for your condition.

Ask about alternatives: For dandruff and seborrheic dermatitis, selenium sulfide or ciclopirox shampoos are effective alternatives. For skin infections, terbinafine or clotrimazole may be just as effective.

Check mail-order: If your insurance plan uses a mail-order pharmacy, this may be a reliable supply channel that bypasses local stock issues.

Looking Ahead

With no national shortage on record in 2026, ketoconazole's availability outlook remains stable for generic formulations. The challenges are primarily localized and formulation-specific. Patients who proactively check stock before running out — and who know their alternatives — are best positioned to manage any gaps. For the full explanation of why ketoconazole can be hard to find, see: Why Is Ketoconazole Hard to Find? [Explained for 2026].